COMMUNIQUÉS West-GlobeNewswire

Saxenda® provides consistent weight loss and improvements in blood glucose control across BMI categories after three years of treatment
05/11/2018
Munich, Germany, 14 September 2016 - Results from a post hoc analysis of the three-year part of the phase 3a SCALE (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial show that people [...]
Victoza® lowered the progression of kidney damage in adults with type 2 diabetes at high CV risk
05/11/2018
Munich, Germany, 15 September 2016 - Novo Nordisk today announced that the progression of kidney damage was significantly lower with Victoza ® treatment vs placebo, as measured by urinary albumin creatinine ratio, both [...]
Semaglutide reduced major cardiovascular events by 26% in adults with type 2 diabetes at high cardiovascular risk
05/11/2018
Munich, Germany, 16 September 2016 - Novo Nordisk today announced that semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue administered once-weekly, significantly reduced the risk of the primary [...]
Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access and sustainability needs
02/11/2018
Decision follows FDA request for additional information to complement submission for biosimilar rituximab Sandoz stands behind safety, efficacy and quality of our biosimilar rituximab, which is already approved in EU, [...]
Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology
02/11/2018
Additional analysis from pivotal Phase III SOLAR-1 clinical trial studying investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) and fulvestrant in patients with PIK3CA-mutated HR+/HER2- advanced or [...]
XBiotech présente les développements du troisième trimestre 2018
02/11/2018
La société fournit une vue d'ensemble mise à jour, y compris de son flux clinique et de découverte, ainsi que d'autres initiatives d’entreprise AUSTIN, Texas, 02 nov. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT [...]
CORRECTED: NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings
02/11/2018
AMES, Iowa, Nov. 02, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline yesterday by NewLink Genetics Corporation (NASDAQ:NLNK), the balance statement included in the press release was incorrect. The [...]
FibroGen to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018
02/11/2018
Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT) SAN FRANCISCO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a biopharmaceutical company, today announced that it will [...]
Bespoke Extracts Appoints Niquana Noel as New Chief Executive Officer
02/11/2018
SUNNY ISLES, Fla., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, today announced that the Company’s Board of Directors has [...]
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018
02/11/2018
RANCHO CUCAMONGA, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its Third quarter of 2018 ended September 30, 2018, after [...]
Resverlogix Closes $13.5 Million Private Placement
02/11/2018
CALGARY, Alberta, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has closed a private placement of approximately 4.5 million equity units at a price of [...]
Aclaris Therapeutics to Attend Upcoming Investor Conferences
02/11/2018
WAYNE, Pa., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
OPEN CALL: #MyHhStory AUDIO Project
02/11/2018
Excessive Sweating Story Will Be Selected for Professional Recording & Archived in Library of Congress CENTER VALLEY, Pa., Nov. 02, 2018 (GLOBE NEWSWIRE) -- When someone suffers from hyperhidrosis (Hh), or excessive [...]
Golden Leaf Holdings Reschedules Date of Conference Call for Review of Its Third Quarter 2018 Results
02/11/2018
PORTLAND, Ore., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018
02/11/2018
HOLLISTON, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting its new [...]
Jounce Therapeutics to Present Two Posters from the JTX-2011 Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
02/11/2018
CAMBRIDGE, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Trevena Receives Complete Response Letter for Oliceridine from FDA
02/11/2018
Company to host conference call and webcast on November 5 th CHESTERBROOK, Pa., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) today announced the Company has received a Complete Response Letter (CRL) [...]
U.S. FDA Approves UDENYCA™ (pegfilgrastim-cbqv)
02/11/2018
REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ: CHRS), today announced that the U.S. Food and Drug Administration (FDA) has approved UDENYCA™ (pegfilgrastim-cbqv), the first [...]
N.M. Provider Wins Favorable Ruling in Plant Count Lawsuit
02/11/2018
Ultra Health is the first cannabis provider to win a lawsuit over production regulations SANTA FE, N.M., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Nicole Sena, a medical cannabis caregiver to her infant daughter with a rare [...]

Pages